Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2026-01-07 00:00:00 ET · period of report 2026-01-05 · accession 0001193125-26-006290 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-01-07 | 2026-01-05 | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $4.60 | -35.4K | 276.8K | -11% | -$162.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-01-05 | S | D | 35,416 | $4.60 | 276,809 | D | — | — | (F2) The reporting person acquired 35,416 shares of Class A Common Stock under the issuer's employee stock purchase plan on December 31, 2025. |